Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorM Aref, Ahmed
dc.contributor.authorS Othman, Mohamed
dc.contributor.authorA Mohamed, Amal
dc.contributor.authorA Ibrahim, Wesam
dc.date.accessioned2019-11-05T06:19:33Z
dc.date.available2019-11-05T06:19:33Z
dc.date.issued2015
dc.descriptionMSA Google Scholar
dc.description.abstractInterleukin-10 (IL-10) and interleukin-6 (IL-6) have been reported to be related to hepatocellular carcinoma (HCC) prognosis. This study aimed to investigate the clinical usefulness of serum levels of IL-6 and IL-10 as biomarkers for HCC among high-risk patients.en_US
dc.description.sponsorshipHindawi Publishing Corporationen_US
dc.identifier.citationOthman, M. S., Aref, A. M., Mohamed, A. A., & Ibrahim, W. A. (2013). Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients. ISRN Hepatology, 2013, 1–9. https://doi.org/10.1155/2013/412317 ‌en_US
dc.identifier.doihttps://doi.org/10.1155/2013/412317
dc.identifier.otherhttps://doi.org/10.1155/2013/412317
dc.identifier.urihttps://cutt.ly/trX8ILp
dc.language.isoenen_US
dc.publisherHindawi Publishing Corporationen_US
dc.relation.ispartofseriesISRN hepatology;
dc.subjectUniversity for Serumen_US
dc.subjectInterleukin-6en_US
dc.subjectInterleukin-10en_US
dc.subjectBiomarkersen_US
dc.subjectHepatocellularen_US
dc.subjectCarcinomaen_US
dc.titleSerum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patientsen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
412317.pdf
Size:
1.51 MB
Format:
Adobe Portable Document Format
Description: